143 related articles for article (PubMed ID: 19718740)
1. Mechanistic studies of the transdermal iontophoretic delivery of 5-OH-DPAT in vitro.
Ackaert OW; Van Smeden J; De Graan J; Dijkstra D; Danhof M; Bouwstra JA
J Pharm Sci; 2010 Jan; 99(1):275-85. PubMed ID: 19718740
[TBL] [Abstract][Full Text] [Related]
2. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and pharmacological effect of (S)-5-OH-DPAT following controlled delivery with transdermal iontophoresis.
Ackaert OW; De Graan J; Shi S; Vreeken R; Pasqua OE; Dijkstra D; Westerink BH; Danhof M; Bouwstra JA
J Pharm Sci; 2011 Jul; 100(7):2996-3009. PubMed ID: 21283984
[TBL] [Abstract][Full Text] [Related]
4. The in vitro and in vivo evaluation of new synthesized prodrugs of 5-OH-DPAT for iontophoretic delivery.
Ackaert OW; De Graan J; Capancioni R; Della Pasqua OE; Dijkstra D; Westerink BH; Danhof M; Bouwstra JA
J Control Release; 2010 Jun; 144(3):296-305. PubMed ID: 20230864
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
Nugroho AK; Li GL; Danhof M; Bouwstra JA
Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation.
Nugroho AK; Romeijn SG; Zwier R; de Vries JB; Dijkstra D; Wikström H; Della-Pasqua O; Danhof M; Bouwstra JA
J Pharm Sci; 2006 Jul; 95(7):1570-85. PubMed ID: 16732562
[TBL] [Abstract][Full Text] [Related]
7. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
Dubey S; Kalia YN
J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.
van der Geest R; Danhof M; Boddé HE
Pharm Res; 1997 Dec; 14(12):1798-803. PubMed ID: 9453071
[TBL] [Abstract][Full Text] [Related]
9. Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.
Li GL; Danhof M; Bouwstra JA
Pharm Res; 2001 Nov; 18(11):1509-13. PubMed ID: 11758756
[TBL] [Abstract][Full Text] [Related]
10. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
[TBL] [Abstract][Full Text] [Related]
11. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
[TBL] [Abstract][Full Text] [Related]
12. Alteration of electroosmotic volume flow through skin by polyethylene glycols.
Lee SY; Oh SY
Arch Pharm Res; 2015 Jul; 38(7):1397-405. PubMed ID: 25331332
[TBL] [Abstract][Full Text] [Related]
13. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
[TBL] [Abstract][Full Text] [Related]
14. Capillary zone electrophoresis for the estimation of transdermal iontophoretic mobility.
Abla N; Geiser L; Mirgaldi M; Naik A; Veuthey JL; Guy RH; Kalia YN
J Pharm Sci; 2005 Dec; 94(12):2667-75. PubMed ID: 16258982
[TBL] [Abstract][Full Text] [Related]
15. Modulation of electroosmosis and flux through skin: effect of propylene glycol.
Lee SY; Jeong NY; Oh SY
Arch Pharm Res; 2014 Apr; 37(4):484-93. PubMed ID: 24101411
[TBL] [Abstract][Full Text] [Related]
16. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
[TBL] [Abstract][Full Text] [Related]
17. Effect of amino acid sequence on transdermal iontophoretic peptide delivery.
Schuetz YB; Naik A; Guy RH; Kalia YN
Eur J Pharm Sci; 2005 Dec; 26(5):429-37. PubMed ID: 16143501
[TBL] [Abstract][Full Text] [Related]
18. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.
Luzardo-Alvarez A; Delgado-Charro MB; Blanco-Méndez J
Pharm Res; 2001 Dec; 18(12):1714-20. PubMed ID: 11785691
[TBL] [Abstract][Full Text] [Related]
19. Transdermal iontophoretic delivery of triptorelin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
[TBL] [Abstract][Full Text] [Related]
20. Iontophoretic delivery of apomorphine: from in-vitro modelling to the Parkinson patient.
Junginger HE
Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S57-75. PubMed ID: 12460716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
